Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells
Clinical Rheumatology Mar 28, 2018
Schramm-Luc A, et al. - This study was conducted to determine age-related differences in cellular functions, which could predict the response to treatment with tumor necrosis factor (TNF) α inhibitors in ankylosing spondylitis (AS) patients. They noted that TNFα-producing CD8 cells could mediate the influence of age on the response to anti-TNFα treatment in AS patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
